ポイントオブケア脂質検査の市場規模、シェア、動向分析レポート：製品別、用途別、適応疾患別、最終用途別、地域別、セグメント別予測、2025年～2030年

ポイントオブケア脂質検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のポイントオブケア脂質検査市場は2030年までに11億米ドルに達し、予測期間中にCAGR 6.5％で拡大すると予測されています。

心血管疾患、糖尿病、腎障害のような慢性疾患の有病率の上昇は、市場成長に寄与する主要な要因であり、これらの疾患はしばしば効果的な管理のために頻繁な脂質モニタリングを必要とします。心血管合併症は、脂質レベルの上昇や全身性炎症などの要因がリスクを増大させる腎臓病患者にとって依然として大きな懸念事項です。

さらに、この動向は、脂質不均衡の早期発見が長期的な健康リスクの軽減に役立つという、予防医療に対する広範な重点化と一致しています。携帯型検査機器は、診療所、病院、家庭でリアルタイムの結果を得ることができ、患者のケアを合理化し、個人が積極的に健康を管理できるようにします。これらのツールをデジタル・プラットフォームと統合することで、パンデミック時に勢いを増した遠隔モニタリングが可能になり、不必要な臨床受診を減らすために引き続き有効です。

ポイントオブケア脂質検査市場レポート・ハイライト

• 消耗品が製品セグメントを支配し、2024年には61.9%の最大売上シェアを占めました。この背景には、迅速で使いやすい検査手順のための使い捨て消耗品のニーズがあります。
• 機器は、予測期間中にCAGR 6.6%で成長すると予想されます。これは、最新の分析装置の精度の向上、機動性、接続性の特徴によるもので、分散化された状況に最適です。
• 高脂血症は、2024年に46.9%の最大売上シェアを占めました。これは主に、糖尿病や心血管疾患などの慢性疾患の迅速かつ効果的な管理の必要性が高まっていることが背景にあります。
• 高トリグリセリド血症は、スピードとアクセシビリティを向上させる検査技術の急速な開発により、予測期間中にCAGR 7.0％で成長する見込みです。
• 脂質・リポ蛋白障害が市場を席巻し、2024年の収益シェアは38.7％で最大。アテローム性動脈硬化症は、2025年から2030年にかけて著しいCAGRで成長すると予測されます。
• 病院セグメントは市場で支配的な地位を占め、2024年には32.2％と最大の収益シェアを占めました。病院は、適切な診断と慢性状態の管理を可能にし、患者の転帰を向上させるために、迅速で正確な脂質検査を必要としています。
• 北米は世界のポイントオブケア脂質検査市場を独占し、2024年に43.6％の最大収益シェアを占めました。これは主に、ポイントオブケア検査を遠隔医療プラットフォームに組み込むことで、使いやすさと患者エンゲージメントが向上するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界のポイントオブケア脂質検査市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 世界のポイントオブケア脂質検査市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析

第4章 世界のポイントオブケア脂質検査市場：製品ビジネス分析

• 製品セグメントダッシュボード
• ポイントオブケア脂質検査市場：製品変動分析
• 世界のポイントオブケア脂質検査市場規模と動向分析（製品別、2018～2030年）
• 機器
• 消耗品

第5章 世界のポイントオブケア脂質検査市場：用途ビジネス分析

• 用途セグメントダッシュボード
• ポイントオブケア脂質検査市場：用途変動分析
• 世界のポイントオブケア脂質検査市場規模と動向分析（用途別、2018～2030年）
• 高脂血症
• 高トリグリセリド血症
• タンジール病
• 高リポタンパク血症
• 家族性高コレステロール血症
• その他

第6章 世界のポイントオブケア脂質検査市場：適応疾患ビジネス分析

• 適応疾患セグメントダッシュボード
• ポイントオブケア脂質検査市場：適応疾患変動分析
• 世界のポイントオブケア脂質検査市場規模と動向分析（適応疾患別、2018～2030年）
• 脂質およびリポタンパク質疾患
• 動脈硬化症
• 肝臓と腎臓の病気
• 糖尿病
• その他

第7章 世界のポイントオブケア脂質検査市場：最終用途のビジネス分析

• 最終用途セグメントダッシュボード
• ポイントオブケア脂質検査市場：最終用途変動分析
• 世界のポイントオブケア脂質検査市場規模と動向分析（最終用途別、2018～2030年）
• 病院
• クリニック
• 調査および診断研究所
• その他

第8章 世界のポイントオブケア脂質検査市場：地域の推定・動向分析

• 地域市場ダッシュボード
• 地域別市場シェア分析、2024年および2030年
• 地域別世界のポイントオブケア脂質検査市場：主なポイント
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • Key Company Heat Map Analysis, 2024
• 企業プロファイル
  • Callegari
  • Abbott Laboratories
  • MiCoBio
  • Nova Biomedical Corporation
  • VivaChek Biotech（Hangzhou）Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • SD Biosensor, Inc e

List of Tables

• Table 1. List Of Abbreviations
• Table 2. Global Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 3. Global Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 4. Global Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 5. Global Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 6. Global Point of Care Lipid Test Market, By Region, 2018 - 2030 (USD Million)
• Table 7. North America Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
• Table 8. North America Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 9. North America Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 10. North America Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 11. North America Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 12. U.S. Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 13. U.S. Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 14. U.S. Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 15. U.S. Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 16. Canada Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 17. Canada Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 18. Canada Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 19. Canada Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 20. Mexico Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 21. Mexico Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 22. Mexico Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 23. Mexico Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 24. Europe Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
• Table 25. Europe Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 26. Europe Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 27. Europe Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 28. Europe Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 29. Germany Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 30. Germany Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 31. Germany Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 32. Germany Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 33. UK Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 34. UK Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 35. UK Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 36. UK Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 37. France Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 38. France Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 39. France Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 40. France Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 41. Italy Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 42. Italy Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 43. Italy Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 44. Italy Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 45. Spain Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 46. Spain Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 47. Spain Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 48. Spain Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 49. Denmark Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 50. Denmark Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 51. Denmark Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 52. Denmark Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 53. Sweden Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 54. Sweden Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 55. Sweden Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 56. Sweden Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 57. Norway Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 58. Norway Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 59. Norway Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 60. Norway Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 61. Asia Pacific Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
• Table 62. Asia Pacific Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 63. Asia Pacific Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 64. Asia Pacific Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 65. Asia Pacific Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 66. China Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 67. China Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 68. China Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 69. China Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 70. Japan Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 71. Japan Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 72. Japan Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 73. Japan Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 74. India Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 75. India Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 76. India Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 77. India Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 78. South Korea Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 79. South Korea Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 80. South Korea Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 81. South Korea Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 82. Australia Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 83. Australia Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 84. Australia Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 85. Australia Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 86. Thailand Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 87. Thailand Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 88. Thailand Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 89. Thailand Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 90. Latin America Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
• Table 91. Latin America Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 92. Latin America Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 93. Latin America Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 94. Latin America Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 95. Brazil Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 96. Brazil Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 97. Brazil Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 98. Argentina Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 99. Argentina Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 100. Argentina Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 101. Argentina Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 102. MEA Point of Care Lipid Test Market, By Region, 2018 - 2030 (USD Million)
• Table 103. MEA Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 104. MEA Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 105. MEA Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 106. MEA Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 107. South Africa Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 108. South Africa Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 109. South Africa Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 110. South Africa Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 111. Saudi Arabia Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 112. Saudi Arabia Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 113. Saudi Arabia Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 114. Saudi Arabia Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 115. UAE Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 116. UAE Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 117. UAE Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 118. UAE Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
• Table 119. Kuwait Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
• Table 120. Kuwait Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
• Table 121. Kuwait Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
• Table 122. Kuwait Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Interviews
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 QFD Modeling for Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 Point of Care Lipid Test Market: Market Outlook
• Fig. 10 Point of Care Lipid Test Competitive Insights
• Fig. 11 Parent Market Outlook
• Fig. 12 Related/Ancillary Market Outlook
• Fig. 13 Penetration and Growth Prospect Mapping
• Fig. 14 Industry Value Chain Analysis
• Fig. 15 Point of Care Lipid Test Market Driver Impact
• Fig. 16 Point of Care Lipid Test Market Restraint Impact
• Fig. 17 Point of Care Lipid Test Market Strategic Initiatives Analysis
• Fig. 18 Point of Care Lipid Test Market: Product Movement Analysis
• Fig. 19 Point of Care Lipid Test Market: Product Outlook and Key Takeaways
• Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030
• Fig. 21 Consumables Market Estimates and Forecast, 2018 - 2030
• Fig. 22 Point of Care Lipid Test Market: Application Movement Analysis
• Fig. 23 Point of Care Lipid Test Market: Application Outlook and Key Takeaways
• Fig. 24 Hyperlipidemia Market Estimates and Forecast, 2018 - 2030
• Fig. 25 Hypertriglyceridemia Market Estimates and Forecast, 2018 - 2030
• Fig. 26 Tangier Disease Indication Market Estimates and Forecast, 2018 - 2030
• Fig. 27 Hyperlipoproteinemia Market Estimates and Forecast, 2018 - 2030
• Fig. 28 Familial Hypercholesterolemia Market Estimates and Forecast, 2018 - 2030
• Fig. 29 Others Market Estimates and Forecast, 2018 - 2030
• Fig. 30 Point of Care Lipid Test Market: Disease Indication Movement Analysis
• Fig. 31 Point of Care Lipid Test Market: Disease Indication Outlook and Key Takeaways
• Fig. 32 Lipid and Lipoprotein Disorders Market Estimates and Forecasts, 2018 - 2030
• Fig. 33 Atherosclerosis Market Estimates and Forecasts, 2018 - 2030
• Fig. 34 Liver and Renal Diseases Market Estimates and Forecasts, 2018 - 2030
• Fig. 35 Diabetes Mellitus Market Estimates and Forecasts, 2018 - 2030
• Fig. 36 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 37 Point of Care Lipid Test Market: End Use Movement Analysis
• Fig. 38 Point of Care Lipid Test Market: End Use Outlook and Key Takeaways
• Fig. 39 Hospitals Market Estimates and Forecasts, 2018 - 2030
• Fig. 40 Clinics Market Estimates and Forecasts, 2018 - 2030
• Fig. 41 Research and Diagnostic Laboratories Market Estimates and Forecasts, 2018 - 2030
• Fig. 42 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 43 Global Point of Care Lipid Test Market: Regional Movement Analysis
• Fig. 44 Global Point of Care Lipid Test Market: Regional Outlook and Key Takeaways
• Fig. 45 North America Market Estimates and Forecasts, 2018 - 2030
• Fig. 46 U.S. Market Estimates and Forecasts, 2018 - 2030
• Fig. 47 Canada Market Estimates and Forecasts, 2018 - 2030
• Fig. 48 Mexico Market Estimates and Forecasts, 2018 - 2030
• Fig. 49 Europe Market Estimates and Forecasts, 2018 - 2030
• Fig. 50 UK Market Estimates and Forecasts, 2018 - 2030
• Fig. 51 Germany Market Estimates and Forecasts, 2018 - 2030
• Fig. 52 France Market Estimates and Forecasts, 2018 - 2030
• Fig. 53 Italy Market Estimates and Forecasts, 2018 - 2030
• Fig. 54 Spain Market Estimates and Forecasts, 2018 - 2030
• Fig. 55 Denmark Market Estimates and Forecasts, 2018 - 2030
• Fig. 56 Sweden Market Estimates and Forecasts, 2018 - 2030
• Fig. 57 Norway Market Estimates and Forecasts, 2018 - 2030
• Fig. 58 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
• Fig. 59 China Market Estimates and Forecasts, 2018 - 2030
• Fig. 60 Japan Market Estimates and Forecasts, 2018 - 2030
• Fig. 61 India Market Estimates and Forecasts, 2018 - 2030
• Fig. 62 Thailand Market Estimates and Forecasts, 2018 - 2030
• Fig. 63 South Korea Market Estimates and Forecasts, 2018 - 2030
• Fig. 64 Australia Market Estimates and Forecasts, 2018 - 2030
• Fig. 65 Latin America Market Estimates and Forecasts, 2018 - 2030
• Fig. 66 Brazil Market Estimates and Forecasts, 2018 - 2030
• Fig. 67 Argentina Market Estimates and Forecasts, 2018 - 2030
• Fig. 68 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 69 South Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 70 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
• Fig. 71 UAE Market Estimates and Forecasts, 2018 - 2030
• Fig. 72 Kuwait Market Estimates and Forecasts, 2018 - 2030

Point Of Care Lipid Test Market Growth & Trends:

The global point of care lipid test market is anticipated to reach USD 1.1 billion by 2030 and is anticipated to expand at a CAGR of 6.5% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic conditions like cardiovascular diseases, diabetes, and kidney disorders is a key driver contributing to the market growth, as these conditions often necessitate frequent lipid monitoring for effective management. Cardiovascular complications remain a major concern for patients with kidney disease, where factors such as elevated lipid levels and systemic inflammation increase risks.

Furthermore, this trend aligns with the broader emphasis on preventive healthcare, where early detection of lipid imbalances helps mitigate long-term health risks. Portable testing devices enable real-time results at clinics, hospitals, or homes, streamlining patient care and empowering individuals to manage their health proactively. The integration of these tools with digital platforms supports remote monitoring, a practice that gained momentum during the pandemic and remains relevant for reducing unnecessary clinical visits.

Point Of Care Lipid Test Market Report Highlights:

• Consumables dominated the product segment and accounted for the largest revenue share of 61.9% in 2024. This is attributed to the need for disposable and single-use consumables for rapid, user-friendly testing procedures.
• Instruments are expected to grow at a CAGR of 6.6% over the forecast period, owing to contemporary analyzers' improved accuracy, mobility, and connectivity features, which make them perfect for decentralized situations.
• The hyperlipidemia held the largest revenue share of 46.9% in 2024, primarily driven by the rising necessity for quick, effective management of chronic diseases such as diabetes and cardiovascular disease.
• Hypertriglyceridemia is expected to grow at a CAGR of 7.0% over the forecast period, owing to the rapid developments in testing technologies that improve speed and accessibility.
• Lipid and lipoprotein disorders dominated the market, with the largest revenue share of 38.7% in 2024. Atherosclerosis is expected to grow at a significant CAGR from 2025 to 2030.
• The hospitals segment held the dominant position in the market and accounted for the largest revenue share, 32.2%, in 2024. Hospitals need quick, precise lipid testing to allow appropriate diagnosis and management of chronic situations, enhancing patient outcomes.
• North America dominated the global point-of-care lipid test market and accounted for the largest revenue share of 43.6% in 2024, primarily due to the incorporation of point-of-care testing with telehealth platforms, which improves user-friendliness and patient engagement.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Disease Indication
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. Disease Indication Outlook
  • 2.2.4. End Use Outlook
  • 2.2.5. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Point of Care Lipid Test Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Global Point of Care Lipid Test Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Global Point of Care Lipid Test Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Point of Care Lipid Test Market: Product Movement Analysis
• 4.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Point of Care Lipid Test Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Point of Care Lipid Test Market: Application Movement Analysis
• 5.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
• 5.4. Hyperlipidemia
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Hypertriglyceridemia
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Tangier Disease
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Hyperlipoproteinemia
  • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. Familial Hypercholesterolemia
  • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Point of Care Lipid Test Market: Disease Indication Business Analysis

• 6.1. Disease Indication Segment Dashboard
• 6.2. Point of Care Lipid Test Market: Disease Indication Movement Analysis
• 6.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By Disease Indication, 2018 to 2030 (USD Million)
• 6.4. Lipid and Lipoprotein Disorders
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Atherosclerosis
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Liver and Renal Diseases
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.7. Diabetes Mellitus
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Point of Care Lipid Test Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Point of Care Lipid Test Market: End Use Movement Analysis
• 7.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.5. Clinics
  • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.6. Research and Diagnostic Laboratories
  • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Global Point of Care Lipid Test Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Global Point of Care Lipid Test Market by Regional: Key Takeaways
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key Country Dynamics
    • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.1.3. Competitive Scenario
    • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Germany
    • 8.5.1.1. Key Country Dynamics
    • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.1.3. Competitive Scenario
    • 8.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.5.3. Competitive Scenario
    • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Denmark
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.6.3. Competitive Scenario
    • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.7.3. Competitive Scenario
    • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Norway
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.8.3. Competitive Scenario
    • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key Country Dynamics
    • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.1.3. Competitive Scenario
    • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Thailand
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.7.1.3. Competitive Scenario
    • 8.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Argentina
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. South Africa
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.1.3. Competitive Scenario
    • 8.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.3. UAE
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.3.3. Competitive Scenario
    • 8.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.4.3. Competitive Scenario
    • 8.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. Key Company Heat Map Analysis, 2024
• 9.4. Company Profiles
  • 9.4.1. Callegari
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Abbott Laboratories
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. MiCoBio
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Nova Biomedical Corporation
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. VivaChek Biotech (Hangzhou) Co., Ltd.
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. F. Hoffmann-La Roche Ltd.
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Menarini Group
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. SD Biosensor, Inc e
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives